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Abstract
BACKGROUND—Arsenic exposure has been linked to epigenetic modifications such as DNA
methylation in in vitro and animal studies. This association has also been explored in highly
exposed human populations, but studies among populations environmentally exposed to low
arsenic levels are lacking.
METHODS—We evaluated the association between exposure to arsenic, measured in toenails,
and blood DNA methylation in Alu and Long Interspersed Nucleotide Element-1 (LINE-1)
repetitive elements in elderly men environmentally exposed to low levels of arsenic. We also
explored potential effect modification by plasma folate, cobalamin (vitamin B12), and pyridoxine
(vitamin B6). The study population was 581 participants from the Normative Aging Study in
Boston, of whom 434, 140, and 7 had 1, 2, and 3 visits, respectively, between 1999-2002 and
2006-2007. We used mixed-effects models and included interaction terms to assess potential effect
modification by nutritional factors.
RESULTS—There was a trend of increasing Alu and decreasing LINE-1 DNA methylation as
arsenic exposure increased. In subjects with plasma folate below the median (< 14.1 ng/ml),
arsenic was positively associated with Alu DNA methylation (β=0.08 [95% confidence interval =
0.03 to 0.13] for one interquartile range [0.06μg/g] increase in arsenic) while a negative
association was observed in subjects with plasma folate above the median (β=-0.08 [-0.17 to
0.01]).
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CONCLUSIONS—We found an association between arsenic exposure and DNA methylation in
Alu repetitive elements that varied by folate level. This suggests a potential role for nutritional
factors in arsenic toxicity.
Arsenic is a ubiquitous environmental contaminant and the number-one chemical on the
Environmental Protection Agency's CERCLA Priority List of Hazardous Substances.1
Arsenic has been associated with increased risk of cancer,2 cardiovascular disease,3 and
neurologic deficits,4 although the mechanisms through which it acts are likely diverse. One
potential pathway is through epigenetic changes, in that arsenic affects methylation
metabolism and also is an oxidant.4-6 Both properties are thought to influence DNA
methylation.7-9 DNA methylation, the most well-studied epigenetic mechanism, involves the
addition of methyl-groups on cytosines to form 5-methyl cytosine (5-mC), which can repress
gene expression due to a closed chromatin structure. DNA methylation also plays an
important role in maintaining genome integrity by silencing the transcription of repetitive
DNA sequences and endogenous transposons.10 A large proportion of the human genome is
composed of Class I transposons and retrotransposons (collectively referred to as “repetitive
elements”), which are viral DNA remnants that can move to different positions within the
genome of a single cell. The most abundant families of retrotransposons are Alu and
LINE-1, which represent approximately 30% of the human DNA.11,12 Hypomethylation of
these otherwise heavily methylated elements13 can enhance their activity as
retrotransposons, which can in turn adversely affect the normal function of cells by inserting
mutations14 or introducing genomic instability.10 Epigenetic modifications in Alu and
LINE-1 elements have been associated with aging and with various risk factors for the same
diseases associated with arsenic, such as cancer, cardiovascular and neurologic
diseases.15-18
Global and gene-specific methylation changes have been linked to arsenic in in vitro, animal
and human studies.5,6,19-26 Two studies have examined the association of arsenic with
global DNA methylation in humans, and both found a positive association.5,23 Arsenic
consumes methyl groups provided by the main methyl donor, intracellular S-
adenosylmethionine (SAM). If critical dietary sources such as folate are relatively low, this
may result in hypomethylation of competing substrates such as DNA. Folate is needed to
methylate homocysteine to form methionine, the precursor of SAM, a reaction that is
catalyzed by a vitamin B12-containing methyltransferase. Therefore the effects of arsenic
might be modified by the availability of methyl donors and one-carbon metabolism factors
such as vitamins B12 and B6.5 However, the few published human studies have focused
primarily on highly exposed populations, in which the impact of dietary factors on arsenic
metabolism and DNA methylation would likely differ substantially from persons with lower
arsenic exposure. To our knowledge no studies are available among people exposed to low
arsenic levels.
We hypothesized that As exposure was associated with decreased DNA Alu and LINE-1
methylation. We examined this association in a population of environmentally exposed
elderly men and explored potential modification by plasma folate, B12, and B6.
METHODS
Study population
The study population originated from the Normative Aging Study, a cohort of community-
dwelling men in eastern Massachusetts that has been followed by the Veterans
Administration since 1963.27 Participants visit the Veterans Affair Outpatient Clinic in
Boston for comprehensive clinical examinations and standard laboratory tests every 3-5
years. Prior to each scheduled visit, participants are asked to collect and bring their toenail
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clippings. The study visits occurred early in the morning after fasting overnight and
abstaining from smoking. The annual attrition rate has been approximately 1%.
Our study period extended from 1 March 1999 to 12 November 2002 and from 10 May 2006
to 7 November 2007 (toenail samples were not collected between 13 November 2002 and 9
May 2006 due to a hiatus in grant funding). Of the 767 participants who had at least one
follow-up visit during the study period, 744 (97%) had at least one available DNA
methylation measurement in either Alu or LINE-1 from blood DNA, and 735 had both Alu
and LINE-1 measurements. DNA methylation was quantified in every blood sample at three
Cytosine-phosphate-Guanine (CpG) dinucleotide loci. Among these participants, 594
contributed a toenail sample. We excluded participants’ visits with invalid DNA methylation
(1 visit), invalid toenail arsenic measurement (1 visit), toenail arsenic levels below the
detection limit (3 visits), or missing data on relevant covariates (14 visits). This resulted in
the exclusion of 13 subjects and 19 visits. Final analyses were performed on 581
participants, of whom 434, 140, and 7 had 1, 2, and 3 visits, respectively, for a total of 735
visits and 2205 DNA methylation measurements.
The study was approved by the Institutional Review Boards of all participating institutions.
All participants gave written informed consent before the study.
Toenail sample analysis
Study participants collected toenail clippings from all 10 toes and brought them to each visit.
After cleaning, toenail samples were analyzed by inductively coupled plasma mass
spectrometry (Elan 6100, Perkin Elmer, Norwark, CT), as detailed in the eAppendix 1
(http://links.lww.com). We measured each sample five times and used the average as the
analytic value.
DNA methylation analysis
Seven-ml blood samples were collected in EDTA tubes during each study visit. Buffy coat
was extracted and stored in a cell lyses solution until DNA extraction. All samples were
coded and frozen at –20°C. Samples were sent to the laboratory in five batches. DNA was
extracted using QiAmp DNA blood kits (QIAGEN, Hilden, Germany). The samples were
bisulfite-treated using the EZ DNA Methylation-Gold™ Kit (Zymo Research, Orange, CA,
USA). Repetitive elements DNA methylation was quantified by PCR and pyrosequencing
using the Pyromark MD System (Pyrosequencing Inc., Westborough, MA). Pyrosequencing
was performed using previously described methods for analyzing the methylation of
repetitive elements13 with minor modifications described elsewhere.16 Each sample was
pyrosequenced in duplicates.
The degree of methylation in both Alu and LINE-1 repetitive elements was measured at
each of three CpG dinucleotide loci that are repeated over the human genome with the
sequence of interest. Methylation was expressed as the percentage of methylated cytosines
(%5mC) over the sum of methylated and unmethylated cytosines. To increase the precision
of our results, we used all three CpG loci measurements in the statistical analysis. The
within-sample coefficients of variation (CVs) were 3.47, 4.04 and 5.35 for the first, second
and third Alu locus, respectively, and 1.58, 1.36 and 1.91 for the first, second and third
LINE-1 locus, respectively. Each plate included controls containing water, annealing
solution, binding solution, and PCR product.
Folate and vitamins B12 and B6 analysis
At each visit, plasma folate and vitamin B12 concentrations were measured by radioassay
with the use of a commercially available kit from Bio-Rad (Hercules, CA), and plasma
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vitamin B6 concentration was measured enzymatically. The CVs for the folate, B12, and B6
assays were 4.3%, 4.7%, and 5.0%, respectively. Further details are found elsewhere.28
Covariate assessment
At each study visit, extensive physical examination, anthropometric, questionnaire and
laboratory data were collected. Height and weight measurements were included in the
physical examination, and body mass index (BMI) was calculated as weight(kg)/height(m)2.
A self-administered questionnaire was employed to collect health- and lifestyle-related
information, including medical history and cigarette smoking. Medical information was
confirmed by an on-site physician. Alcohol consumption was determined by a standardized
semi-quantitative food frequency questionnaire.29
Statistical analysis
Participants were compared with non-participants at their first visit during the study period.
We used t tests to compare two groups of normally distributed continuous variables, while
the Wilcoxon rank-sum test was used to compare two groups of skewed variables. Chi-
square or Fisher's exact tests were used to test for group differences in the categorical
variables. Pearson correlation coefficient (r) was used to calculate the correlation between
two normally distributed variables. We calculated the intraclass correlation coefficients
(ICCs) for Alu and LINE-1 DNA methylation by running a mixed-effects model with a
random effect for each participant.
We evaluated the association between toenail arsenic concentration and repetitive elements
DNA methylation measured in blood samples collected at the same visit when toenail
samples were brought in. Separate models for Alu and LINE-1 DNA methylation were
fitted. DNA methylation was analyzed at three separate CpG dinucleotide loci for each
subject. Linear mixed-effects models were used to account for the correlation among
repeated measurements within the same subject. These included a random intercept for each
subject in order to account for the heterogeneity in their overall level of methylation.
We considered possible confounders or important predictors of the outcome—age, cigarette
smoking status, pack-years, BMI, alcohol consumption status, percent lymphocytes in
differential leukocyte counts, season and day of the week of the visit, and laboratory batch
for the DNA blood samples—on the basis of their biologic significance and information
from previous studies.5,16,30,31 Age, laboratory batch and CpG dinucleotide locus number
were a priori included in the models, while the rest of the covariates were added based on
whether their addition to the model significantly changed the effect estimate or improved the
model's fit as evaluated by a likelihood ratio test. The final models included age, laboratory
batch, CpG dinucleotide locus number, percent lymphocytes, BMI, and alcohol drinking
status. The structure of the fitted models is provided in eAppendix 2 (http://links.lww.com).
To examine possible non-linear associations between arsenic and DNA methylation levels,
we modeled toenail arsenic as a penalized spline by using generalized additive models. The
penalized spline is a cubic regression spline with 10 knots; however, the coefficients of the
spline are penalized, which constrains the number of degrees of freedom used.32 We used
multiple generalized cross-validation to choose the degree of penalty. With this method, the
data are divided into subsets, and after omitting each subset in turn, the model is
successively fit. The fitted model is subsequently used to “predict” the response for the
subset that was left out. This procedure is repeated with different smoothing parameter
values, which suggests a value that minimizes the cross-validation estimate of the mean-
squared error.33 The model fit was also examined by identifying outliers and other highly
influential data values by means of graphical and visual inspection and calculation of
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influence diagnostics. The list of the diagnostics is included in eAppendix 3
(http://links.lww.com).
To explore potential effect modification of the main associations by plasma folate, vitamin
B12 and vitamin B6, we included an interaction term between toenail arsenic and each of the
nutritional factor variables in our main-effects models. The nutritional-factor variables were
dichotomized at the median.
All mixed-effects models and influence diagnostics were conducted using SAS (version 9.2
SAS Institute Inc., Cary, NC) while the generalized additive models were run in R (version
2.10.1, R Foundation of Statistical Computing, www.r-project.org).
RESULTS
No meaningful differences were found between participants (n=581) and non-participants
(n=186) at the baseline visit in terms of age, BMI, smoking or drinking status, percent
lymphocytes, and average Alu and LINE-1 DNA methylation (data not shown). The ICCs
for Alu and LINE-1 methylation were 0.01 and 0.34, respectively, indicating that there is
intraindividual variability in Alu methylation with time, while LINE-1 methylation remains
rather stable.
At the baseline visit, study participants had a mean age of 72 years (SD=7). The majority
were former smokers (67%) and had consumed fewer than 2 drinks per day in the year
preceding the visit (81%) (Table 1). DNA methylation in Alu elements was weakly and
inversely correlated (r=-0.2) with DNA methylation in LINE-1 elements.
In the generalized additive models, the generalized cross-validation estimated one degree of
freedom when fitting a penalized spline for toenail arsenic in both LINE-1 and Alu DNA
methylation models. We therefore concluded that modeling the exposure of interest as a
linear term in our models was appropriate.
In the final covariate-adjusted linear mixed effects models, arsenic levels showed a trend of
negative association with LINE-1 methylation (β=-0.05 per one interquartile range
[IQR=0.06μg/g] increase in toenail arsenic [95% confidence interval = -0.11 to 0.02]), while
a trend of positive association was observed between arsenic and Alu methylation (β=0.03
[-0.01 to 0.07]). Further adjusting for smoking status, pack-years, season and day of the
week did not change the estimates (Table 2).
When we examined the main associations in visits with complete data for plasma folate and
vitamins B12 and B6 from 547 participants, the associations retained the same directions (for
LINE-1, β=-0.03 [95% CI= -0.11 to 0.03]; for Alu, 0.04[-0.004 to 0.083]).
Results from the models including the interaction terms are found in Table 3. The
association between arsenic and Alu methylation was modified by plasma folate status. For
a one-IQR (0.06μg/g) increase in toenail arsenic, Alu methylation decreased by 0.08% for
participants with plasma folate above the median (>14.1 ng/ml), while for participants with
plasma folate below the median, an increase of 0.08% in Alu methylation was observed for
the same increment of toenail arsenic. We observed no difference in the association between
arsenic and LINE-1 methylation in men with plasma folate below or above the median, or in
the association between arsenic and Alu or LINE-1 in men with plasma vitamins B12 or B6
above and below the median (Figure).
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DISCUSSION
In this cohort of elderly men environmentally exposed to low arsenic levels, LINE-1 DNA
methylation tended to decrease, while, contrary to our hypothesis, Alu DNA methylation
tended to increase with increasing arsenic (although these associations were weak).
Methylation decreased with age. For a one-year increase in age, Alu and LINE-1 DNA
methylation decreased by 0.01% (95% CI = -0.03 to -0.00) and 0.02% (-0.04 to -0.00)
respectively. By comparison, the associations with arsenic were stronger for LINE-1
(β=-0.05 [95% CI= -0.11 to 0.02) and in the other direction for Alu (β=0.03[-0.01 to 0.07]).
Similarly the association of percent lymphocytes was in the expected direction (for 1%
increase in percent lymphocytes, LINE-1 and Alu DNA methylation decreased by 0.02%
[-0.04% to -0.01%] and 0.01% [-0.02% to -0.00%], respectively).31 Stronger negative
associations between other environmental exposures (such as lead, SO4, PM2.5 and black
carbon) and LINE-1 methylation have also been found among participants in this
study.30,34,35 When we examined potential confounding of our associations of interest by
lead and particulate air pollution, no confounding was detected (eAppendix 4,
http://links.lww.com).
Folate nutritional status modified the association between arsenic and Alu DNA
methylation. Men with lower values of plasma folate showed an increase in Alu DNA
methylation with increasing arsenic, while a decrease of the same magnitude was observed
among men with higher values of plasma folate. No differences in the associations of arsenic
with LINE-1 DNA methylation were observed in people with lower or higher values of B
vitamins. The same was true for the association between arsenic and Alu methylation in men
with lower or higher values of plasma vitamins B12 and B6. Nonetheless, all the above
associations appeared stronger among men with lower values of plasma folate and vitamins
B12, and B6, indicating a possible role of vitamin B nutrients in the arsenic mechanism of
action.
One mechanism through which arsenic may be associated with DNA methylation is by
interference with methyl donor availability.7 Methyl groups provided by the methyl donor
S-adenosylmethionine are consumed during the metabolism of arsenic, which can lead to
global DNA hypomethylation. However, this possibility is unlikely in our study population,
given low arsenic levels and high folate values (median plasma folate=30nmol/L at baseline
visit). Hypomethylation can also occur as a result of oxidative DNA damage. Arsenic and
metals in general increase the production of reactive oxygen species (ROS) via redox
cycling,5,6 and long-term exposure to oxidative stress has been associated with oxidative
damage of methylated cytosine residues and gradual loss of cytosine methylation in repeated
elements.8,9 However, it is unlikely that the low levels of arsenic exposure in our study
population would yield sufficient oxidative stress to induce measurable changes in DNA
methylation – which may be why our observed associations were not stronger.
In vitro and animal studies have found an inverse relation between exposure to arsenic and
genomic DNA methylation as measured in hepatic cells.7,25 In human populations, arsenic
has been linked with hypermethylation of tumor-suppressor genes in cancer19,26 and
arsenicosis21,22 patients. In a population chronically exposed to arsenic-contaminated water
in Bangladesh, arsenic exposure was associated with increased genomic blood leukocyte
DNA methylation.5 Our observation of a trend of positive association between arsenic and
Alu DNA methylation seems to be consistent with this finding, but the two studies differ in
several aspects. We used toenails, a measure of longer-term arsenic exposure than blood,
urine or plasma (used by Pilsner et al.5), which reflect more recent exposures. Furthermore,
the average folate levels in our study were nearly three times higher (with a median at
baseline of 13.3ng/ml, or 30nmol/L) than those reported in Pilsner et al. (mean of 9nmol/L).
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This discrepancy could also explain some of the differences in effect modification by plasma
folate between the two studies. We found that men with “low” plasma folate levels
(≤14.1ng/ml or equivalently ≤32nmol/L) showed an increase in Alu DNA methylation with
increasing arsenic. These men would be somewhat comparable to those in the Bangladesh
study5 who were assigned to the “high” folate group (>9nmol/L or >4ng/ml), in which
arsenic exposure was also associated with increased leukocyte DNA methylation.
The markers of DNA methylation were also different; Pilsner and colleagues5 used the
methyl acceptance assay to measure genomic DNA methylation in blood leukocytes, while
we used pyrosequencing to measure Alu and LINE-1 repetitive element methylation.
Although Alu and LINE-1 have both been considered surrogate measures of global
methylation because they capture the global hypomethylation found in cancer tissues, DNA
methylation in these elements could differ from methylation in the rest of the genome. It is
clear that patterns of methylation differ between LINE-1 and Alu. For example, methylation
of LINE-1, but not Alu, was previously associated with traffic particles in this cohort.35 It is
also uncertain whether the two measures reflect global DNA methylation in peripheral blood
methylation. A recent study analyzing 37 blood DNA samples from a case-control study of
breast cancer failed to show any correlation between LINE-1 methylation and global DNA
methylation.36 Lastly, our study population was exposed to very low arsenic levels through
the environment, while the Bangladesh study participants were chronically exposed to
heavily arsenic-contaminated drinking water.
To our knowledge, our study is the first to examine the association between arsenic and
repetitive element DNA methylation. Alu and LINE-1 elements, as retrotransposons,
originate from RNA viruses and first transcribe to RNA, producing a ribonucleoprotein
complex with reverse transcriptase and endonuclease properties. This facilitates the insertion
of the DNA copy back into the genome at a new location, potentially even on a different
chromosome. Retrotransposition may lead to constitutive safeguards to maintain the genome
integrity by reducing or regulating the expression of these elements, which may be why
more than one-third of DNA methylation occurs in these sequences.37 However, recent
evidence has shown they can be transcribed and translated into functional proteins,38 and it
is possible that the environment affects methylation in these sequences, resulting in their
activation or altered gene expression.
While a trend of an inverse relation was observed between arsenic and LINE-1 methylation,
Alu methylation tended to increase with increasing arsenic, which contradicts our a priori
hypothesis that arsenic is associated with decreased DNA methylation. However, blood
DNA methylation in Alu elements was inversely correlated with LINE-1 DNA methylation,
which might indicate that Alu DNA methylation patterns differ from the patterns in other
substrates. Alu and LINE-1 elements are controlled by different mechanisms that are not
fully understood.16 Metals can generate cellular stress through ROS production, and cellular
stressors have been shown to trigger different transcription patterns among Alu and LINE-1
elements.16 It is possible that arsenic could affect Alu and LINE-1 elements in distinct, yet
unknown, ways. It may be relevant that Alu and LINE-1 methylation have previously been
reported to have opposite associations with the risk of incident cardiovascular disease, one
of the potential effects of arsenic exposure.3 Alu was positively associated with
cardiovascular disease,39 whereas LINE-1 methylation was negatively associated.40 Arsenic
exposure has been shown to influence the activity of DNA methyltransferases,25,41 which
could result in DNA hypo- or hypermethylation of repetitive elements. If hypermethylation
occurs, then the proportion of methylated cytosines will increase. As Pilsner et al.5 discuss,
this could lead to higher mutation risk, because deamination of cytosines is more frequent in
the presence of attached methyl-groups, a process that yields C→T transitions.5 This
pathway could potentially explain the carcinogenicity of arsenic.
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We found an interaction between toenail arsenic and plasma folate. Alu DNA methylation
increased in men with plasma folate below the median, while those with higher folate values
had the same magnitude of association but in the opposite direction. This finding was
contrary to our expectation that methylation would decrease with increasing arsenic in men
with lower plasma folate concentrations. In order to be excreted, inorganic arsenic
transforms to the organic forms of monomethylarsonic acid or dimethylarsinic acid through
methylation reactions. These reactions require methyl-groups provided by SAM, through
one-carbon metabolism. Folate and other B-complex vitamins such as B12 and B6, provide
the coenzymes that participate in one-carbon metabolism, which produces SAM, the
universal methyl-group donor for essential substrates such as DNA. Thus, the availability of
methyl nutrients can confer susceptibility to the effects of arsenic through altered DNA
methylation. Folate deficiency has been associated with both arsenic-induced skin lesions
and decreased arsenic methylation,42,43 but the mechanism through which arsenic may
increase Alu DNA methylation in people with lower folate values is unknown.
The lack of stronger associations in our study may be attributed to various factors. Firstly,
the low arsenic exposure levels in our study population may have limited our ability to see a
stronger association. Our participants had toenail arsenic concentrations that ranged between
0.02 μg/g and 1.45 μg/g, similar to those of other U.S.-based study populations.44,45
Occupational sources of arsenic were unlikely in this population, as most of them were
retired at the time of the study. A primary route of human arsenic exposure is water,46 and
the major supply source of water among our study participants was the Massachusetts Water
Resources Authority, in which arsenic is consistently undetectable (< 1.0 μg/L). Thus,
arsenic exposure in our study population likely comes from other common but low-level
environmental sources, such as food, air, soil and dust.4 Arsenic can be detected in food
such as fish and seafood,47 and thus we explored whether the associations were potentially
confounded by fish/seafood intake, but no confounding was detected (data not shown).
Secondly, arsenic may influence DNA methylation only when methyl nutrients are reduced.
This would be consistent with our observation of a tendency of greater associations between
arsenic and Alu or LINE-1 DNA methylation among people with lower values of plasma
folate, B12 and B6.
Previous epidemiologic studies examining whether arsenic affects global or gene-specific
DNA methylation have used non-biomarker exposure measures (e.g. arsenic in water),26 or
biomarkers of recent exposure (blood or urine arsenic).5 Toenails are considered a good
biomarker of exposure in epidemiologic investigations because they are less susceptible to
external contamination than other matrices such as hair44; they are keratin-rich tissue, and
inorganic arsenic tends to accumulate in them due to its high affinity for sulfhydryl groups;
toenail arsenic concentration reflects an integrated measure of arsenic incorporated in the
human body from multiple exposure routes, including water, food, air, soil and dust;48 the
concentration is not influenced by individual differences in arsenic metabolism;49 and the
concentration is indicative of arsenic exposure from the preceding 12-18 months reflecting
longer-term exposure than blood or urine measurements.45 It is possible that longer-term
arsenic exposure rather than recent exposure is more relevant to the adverse health effects of
arsenic, including cancer, ischemic heart disease and neurologic deficits. In our cohort,
toenail arsenic has been positively related to cardiovascular effects, such as systolic and
diastolic blood pressure as well as pulse pressure and QT prolongation, which is a risk factor
for arrhythmia and sudden cardiac death.50,51 If these effects are mediated through DNA
methylation changes, then a measure of longer-term arsenic exposure is more appropriate
when examining the association between arsenic and DNA methylation, which has been
found to remain rather stable within individuals.16
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Our study has several limitations. We did not measure DNA methylation status in arsenic's
target organ tissues but rather in blood leukocytes, which may not represent methylation in
target tissues. However, studies among subjects exposed to arsenic-contaminated water26
and patients with arsenic-induced skin lesions42 have found changes in gene-specific and
genomic DNA methylation from peripheral blood leukocytes. Also, arsenic is an effective
therapy for acute promyelocytic leukemia, indicating that arsenic distributes to these cells
and influences their cellular function.52 Furthermore, normal DNA methylation patterns
have not yet been established,30 but in order to determine them, it is essential to use easily
accessible tissues such as blood.
A major strength of our study is that we explored the association of interest in a group of
men environmentally exposed to arsenic levels that are representative of other US
populations. Thus, our findings can be generalized to adult men exposed to arsenic through
everyday life activities. We used an accurate quantitative analysis with pyrosequencing
technology for measuring DNA methylation at more than one CpG dinucleotide loci.
Additionally, our biomarker of arsenic exposure has been well validated as an integrated
measure of exposure from multiple sources,48 and it reflects medium to long-term exposure,
which is probably more appropriate than recent exposure, given the known adverse health
effects of arsenic. Furthermore, obtaining toenail samples is a non-invasive and convenient
procedure for epidemiologic studies.
In conclusion, we observed a trend of increasing Alu and decreasing LINE-1 DNA
methylation with increasing arsenic in a population of men with generally low arsenic
exposure. Plasma folate seems to act as an effect modifier of the association between arsenic
and Alu DNA methylation. While the mechanisms remain unclear, this finding indicates that
the availability of methyl-nutrients could play a significant role in arsenic toxicity, if the
latter is indeed mediated by DNA methylation. Future studies are needed to identify normal
DNA methylation patterns in repetitive elements and to examine any relation of
environmental exposures with deviations from the normal DNA methylation status.
Identifying the various mechanisms that control Alu and LINE-1 elements will also shed
light on how environmental stimuli affect repetitive sequences. In vitro and animal studies
can provide valuable information on whether arsenic-induced epigenetic modifications in
blood leukocytes are associated with changes in target tissues. Finally, determining whether
epigenetic changes mediate the effect of arsenic on human health and whether this effect is
less profound when methyl-nutrient levels are sufficient will suggest strategies for
decreasing arsenic toxicity.
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eAppendix 1
To remove extraneous contaminants, each sample was pre-cleaned before analysis by the
following procedure: the samples were sonicated for 15 minutes in approximately 10 mL of
1% Triton X-100 solution in 15-mL plastic tubes, rinsed several times with distilled
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deionized water, dried at 60°C for 24 hours in a drying oven and weighed into a 15-ml
plastic tube. The samples were then digested with 1 ml of concentrated HNO3 acid for 24
hours, diluted to 5-ml with deionized water and analyzed by ICP-MS (Elan 6100, Perkin
Elmer, Norwalk, CT) using an external calibration method with tellurium as the internal
standard for As.
Quality control (QC) measures included analyzing the initial calibration verification
standard [standard reference material 1643e (trace elements in water); National Institute of
Standards and Technology Gaithersburg, MD], continuous calibration standards, a solution
of 1 ng/ml mixed-element standard As solution (NIST traceable), and a procedural blank.
The QC sample was Certified Reference Material GBW 07601. Recovery of the QC
standard analysis was 90% -110% with 95% precision.
The inter-assay coefficient of variation was 0.1. The detection limit for the analytical
solution was 0.2 ng/mL. Due to sample weight variability (range: 0.002g-0.9g), the samples
DL varied from 0.001 μg/g to 0.42 μg/g (mean = 0.02 μg/g) (sample DL= DL for the
analytical solution x dilution factor).
eAppendix 2
The structure of the fitted models is described by the following equation:
where Yijk is the DNA methylation level in either Alu or LINE-1 repetitive element CpG
locus i at time j in subject k; β0 is the overall intercept; uk is the random intercept for subject
k; βE is the slope representing the fixed effect of toenail As; βL is the slope representing the
fixed effect of the CpG dinucleotide locus; β' is the vector of the regression coefficients for
the covariates (vector of Xjk) at time j for subject k adjusted in the model; and eijk is the
residual error term.
eAppendix 3
The influence diagnostics included measures of overall influence (i.e. likelihood distance),
measures of influence on the estimates of the fixed effects and of the covariance parameters
(i.e. Cook's D and the multivariate DFFITS statistic), measures of influence on the precision
in the estimates of the fixed effects and of the covariance parameters (i.e. covariance trace
and covariance ratio), measures of changes in the effect estimate of interest when removing
participants or observations.
eAppendix 4
Wright et al. found a negative association between patella lead and LINE-1 DNA
methylation but not Alu.1 Unfortunately, there was a great amount of missing information
on patella lead measurements in our specific study population with only 181 study visits
(from a total of 735) having available patella lead measurements. To evaluate potential
confounding by lead, we examined the correlation between toenail arsenic and patella lead.
We found that there was no correlation (spearman correlation coefficient (rs)= -0.07, p-
value=0.350, n=181). The half life of bone lead is ≥10 years and thus bone lead is
considered a measure of long-term exposure. Therefore, we believed that it would be
reasonable to assign this long-term measure of exposure to the visits of the same individual
that were relatively close in time in order to increase the number of visits with available
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bone lead measurements. We assigned the immediate previous (if previous was not
available, we assigned the immediate next in time) patella lead measurement to the missing
values of patella lead. For those individuals who missed both, the missing value remained
missing. After doing that, the number of visits with available patella lead measurements was
increased to 429 (from a total of 735) and again no correlation between patella lead and
toenail arsenic was detected [rs= -0.04, p-value=0.618 at baseline visit (n=168) and rs=-0.03,
p-value=0.516, for all visits (n=429)]. Since lead exposure was not associated with As
exposure, we did not further considered this covariate in our analysis.
A negative association was found between black carbon exposure and Alu DNA methylation
as well as between SO4 and LINE-1 DNA methylation by Madrigano et al. among NAS
participants.2 Specifically, an interquartile range increase in BC over a 45-, 60- and 90-day
period was associated with a decrease of 0.17% (95%CI, -0.34 to 0.00), 0.21% (95%CI,
-0.39 to -0.03) and 0.31% 5-methylcytosine (95% CI, 0.12-0.50%) in Alu respectively. An
interquartile range increase in SO4 over a 90-day period was associated with a decrease of
0.27% 5mC (0.02-0.52%) in LINE-1. In order to examine the association between the air
pollutants black carbon and SO4 and our exposure of interest, we calculated the spearman
correlation coefficients between toenail arsenic with the 45-, 60-, and 90-day moving
average of black carbon as well as the 90-day moving average of SO4 and the results are
presented in eTable 1. Given the lack of association between toenail arsenic and black
carbon, we did not consider this covariate further in our analysis.
Since the 90-day moving average for SO4 was associated with toenail arsenic, we included
the covariate in our models for LINE-1 to check whether it will influence our findings. Since
there were missing SO4 measurements, we re-ran our models using only the visits which
have data on SO4 and the results for the main effect of toenail arsenic original model and the
model additionally adjusted for SO4 are presented in eTable 2. The main effect of toenail
arsenic on LINE-1 DNA methylation in this restricted population did not change when SO4
was included in the model.
Also, Baccarelli et al. have also reported a negative association between recent higher black
carbon and PM2.5 exposure (7-d moving average) and LINE-1 methylation.3 We explored
whether there was an association between toenail arsenic and both 7-day averages of black
carbon and PM2.5 in our study population and we found no correlation between arsenic and
black carbon (rs=-0.00, p-value=0.997, n=735) or arsenic and PM2.5 (rs=-0.00, p-
value=0.953, n=735). No correlations were also found at first visit only.
Appendix
eTable 1
Spearman correlation coefficients between toenail arsenic and air pollutants among the study
population
Air Pollutant (average) Number of visits Spearman r p-value
Black carbon
    45 days 735 0.05 0.202
    60 days 735 0.02 0.600
    90 days 735 -0.02 0.673
SO4
    90 days 594 0.10 0.014
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Appendix
eTable 2
Estimated changes in LINE-1 DNA methylation associated with one interquartile change
(0.06μg/g) in toenail arsenic among the study population with complete data on SO4
(n=1782 CpG methylation observations from 594 visits).
LINE-1 Observations Beta (95% CI)
Original Modela 1782 0.02 (-0.06 to 0.09)
Additionally adjusted for SO4 1782 0.02 (-0.06 to 0.09)
a
Multivariable adjusted mixed effects model adjusted for age, laboratory batch, CpG locus number, % lymphocytes,
alcohol drinking status, and body mass index.
REFERENCES
1. United States Environmental Protection Agency. [February 20, 2010] Comprehensive
Environmental Response, Compensation, and Liability Act (CERCLA) Priority List of Hazardous
Substances. http://www.epa.gov/superfund/health/contaminants/index.htm.
2. Schuhmacher-Wolz U, Dieter HH, Klein D, Schneider K. Oral exposure to inorganic arsenic:
evaluation of its carcinogenic and non-carcinogenic effects. Crit Rev Toxicol. 2009; 39:271–298.
[PubMed: 19235533]
3. Wang CH, Hsiao CK, Chen CL, et al. A review of the epidemiologic literature on the role of
environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol. 2007;
222:315–326. [PubMed: 17433393]
4. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for arsenic.
U.S. Department of Health and Human Services, Public Health Service; Atlanta, GA: 2007.
5. Pilsner JR, Liu X, Ahsan H, et al. Genomic methylation of peripheral blood leukocyte DNA:
influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr. 2007; 86:1179–1186.
[PubMed: 17921400]
6. Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms
involved in metal-induced oxidative damage. Curr Top Med Chem. 2001; 1:529–539. [PubMed:
11895129]
7. Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP. Chronic inorganic arsenic exposure
induces hepatic global and individual gene hypomethylation: implications for arsenic
hepatocarcinogenesis. Carcinogenesis. 2004; 25:1779–1786. [PubMed: 15073043]
8. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-
CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG
binding protein 2 (MeCP2). Nucleic Acids Res. 2004; 32:4100–4108. [PubMed: 15302911]
9. Pogribny IP, Tryndyak VP, Woods CG, Witt SE, Rusyn I. Epigenetic effects of the continuous
exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome
proliferator activated receptor alpha. Mutat Res. 2007; 625:62–71. [PubMed: 17586532]
10. Hedges DJ, Deininger PL. Inviting instability: Transposable elements, double-strand breaks, and
the maintenance of genome integrity. Mutat Res. 2007; 616:46–59. [PubMed: 17157332]
11. Kazazian HH Jr. Goodier JL. LINE drive. retrotransposition and genome instability. Cell. 2002;
110:277–280. [PubMed: 12176313]
12. Grover D, Mukerji M, Bhatnagar P, Kannan K, Brahmachari SK. Alu repeat analysis in the
complete human genome: trends and variations with respect to genomic composition.
Bioinformatics. 2004; 20:813–817. [PubMed: 14751968]
13. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating
global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res.
2004; 32:e38. [PubMed: 14973332]
14. Kazazian HH Jr. Mobile elements: drivers of genome evolution. Science. 2004; 303:1626–1632.
[PubMed: 15016989]
Lambrou et al. Page 12
Epidemiology. Author manuscript; available in PMC 2013 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
15. Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr. 2009;
21:243–251. [PubMed: 19663042]
16. Bollati V, Schwartz J, Wright R, et al. Decline in genomic DNA methylation through aging in a
cohort of elderly subjects. Mech Ageing Dev. 2009; 130:234–239. [PubMed: 19150625]
17. Bollati V, Baccarelli A, Hou L, et al. Changes in DNA methylation patterns in subjects exposed to
low-dose benzene. Cancer Res. 2007; 67:876–880. [PubMed: 17283117]
18. Rusiecki JA, Baccarelli A, Bollati V, Tarantini L, Moore LE, Bonefeld-Jorgensen EC. Global
DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic
Inuit. Environ Health Perspect. 2008; 116:1547–1552. [PubMed: 19057709]
19. Marsit CJ, Karagas MR, Danaee H, et al. Carcinogen exposure and gene promoter
hypermethylation in bladder cancer. Carcinogenesis. 2006; 27:112–116. [PubMed: 15987713]
20. Chen WT, Hung WC, Kang WY, Huang YC, Chai CY. Urothelial carcinomas arising in arsenic-
contaminated areas are associated with hypermethylation of the gene promoter of the death-
associated protein kinase. Histopathology. 2007; 51:785–792. [PubMed: 17953697]
21. Zhang AH, Bin HH, Pan XL, Xi XG. Analysis of p16 gene mutation, deletion and methylation in
patients with arseniasis produced by indoor unventilated-stove coal usage in Guizhou, China. J
Toxicol Environ Health A. 2007; 70:970–975. [PubMed: 17479413]
22. Smeester L, Rager JE, Bailey KA, et al. Epigenetic changes in individuals with arsenicosis. Chem
Res Toxicol. 2011; 24:165–167. [PubMed: 21291286]
23. Majumdar S, Chanda S, Ganguli B, Mazumder DN, Lahiri S, Dasgupta UB. Arsenic exposure
induces genomic hypermethylation. Environ Toxicol. 2010; 25:315–318. [PubMed: 19437452]
24. Reichard JF, Schnekenburger M, Puga A. Long term low-dose arsenic exposure induces loss of
DNA methylation. Biochem Biophys Res Commun. 2007; 352:188–192. [PubMed: 17107663]
25. Uthus EO, Davis C. Dietary arsenic affects dimethylhydrazine-induced aberrant crypt formation
and hepatic global DNA methylation and DNA methyltransferase activity in rats. Biol Trace Elem
Res. 2005; 103:133–145. [PubMed: 15772437]
26. Chanda S, Dasgupta UB, Guhamazumder D, et al. DNA hypermethylation of promoter of gene p53
and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci. 2006; 89:431–437.
[PubMed: 16251483]
27. Bell B, Rose CL, Damon A. The Normative Aging Study. An interdisciplinary and longitudinal
study of health and aging. Aging and Human Development. 1972; 3:5–17.
28. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A 3rd. High homocysteine and low B vitamins
predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin
Nutr. 2005; 82:627–635. [PubMed: 16155277]
29. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative
food frequency questionnaire. Am J Epidemiol. 1985; 122:51–65. [PubMed: 4014201]
30. Wright RO, Schwartz J, Wright RJ, et al. Biomarkers of lead exposure and DNA methylation
within retrotransposons. Environ Health Perspect. 2010; 118:790–795. [PubMed: 20064768]
31. Zhu ZZ, Hou L, Bollati V, et al. Predictors of global methylation levels in blood DNA of healthy
subjects: a combined analysis. Int J Epidemiol. Sep 15.2010 [Epub ahead of print].
32. Wood S. Modelling and smoothing parameter estimation with multiple quadratic penalties. J R
Statist Soc B. 2000; 62:413–428.
33. Fox, J. Nonparametric Regression. Sage Publications; California: 2002. Appendix to An R and S-
PLUS Companion to Applied Regression..
34. Madrigano J, Baccarelli A, Mittleman MA, et al. Prolonged exposure to particulate pollution,
genes associated with glutathione pathways, and DNA methylation in a cohort of older men.
Environ Health Perspect. 2011; 119:977–982. [PubMed: 21385671]
35. Baccarelli A, Wright RO, Bollati V, et al. Rapid DNA methylation changes after exposure to
traffic particles. Am J Respir Crit Care Med. 2009; 179:572–578. [PubMed: 19136372]
36. Choi JY, James SR, Link PA, et al. Association between global DNA hypomethylation in
leukocytes and risk of breast cancer. Carcinogenesis. 2009; 30:1889–1897. [PubMed: 19584139]
37. Schmid CW. Does SINE evolution preclude Alu function? Nucleic Acids Res. 1998; 26:4541–
4550. [PubMed: 9753719]
Lambrou et al. Page 13
Epidemiology. Author manuscript; available in PMC 2013 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
38. Belancio VP, Deininger PL, Roy-Engel AM. LINE dancing in the human genome: transposable
elements and disease. Genome Med. 2009; 1:97. [PubMed: 19863772]
39. Kim M, Long TI, Arakawa K, Wang R, Yu MC, Laird PW. DNA methylation as a biomarker for
cardiovascular disease risk. PLoS One. 2010; 5:e9692. [PubMed: 20300621]
40. Baccarelli A, Wright R, Bollati V, et al. Ischemic heart disease and stroke in relation to blood
DNA methylation. Epidemiology. 2010; 21:819–828. [PubMed: 20805753]
41. Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP.
Molecular events associated with arsenic-induced malignant transformation of human prostatic
epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol Appl
Pharmacol. 2005; 206:288–298. [PubMed: 16039940]
42. Pilsner JR, Liu X, Ahsan H, et al. Folate deficiency, hyperhomocysteinemia, low urinary
creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin
lesions. Environ Health Perspect. 2009; 117:254–260. [PubMed: 19270796]
43. Gamble MV, Liu X, Ahsan H, et al. Folate, homocysteine, and arsenic metabolism in arsenic-
exposed individuals in Bangladesh. Environ Health Perspect. 2005; 113:1683–1688. [PubMed:
16330347]
44. Karagas MR, Tosteson TD, Blum J, et al. Measurement of low levels of arsenic exposure: a
comparison of water and toenail concentrations. Am J Epidemiol. 2000; 152:84–90. [PubMed:
10901333]
45. Slotnick MJ, Meliker JR, AvRuskin GA, Ghosh D, Nriagu JO. Toenails as a biomarker of
inorganic arsenic intake from drinking water and foods. J Toxicol Environ Health A. 2007;
70:148–158. [PubMed: 17365576]
46. National Research Council's Subcommittee on Arsenic in Drinking Water (NRC). Arsenic in
Drinking Water. National Academy Press; Washington, DC: 1999. p. 177-192.
47. Longnecker MP. On confounded fishy results regarding arsenic and diabetes. Epidemiology. Nov.
2009; 20:821–823.
48. Slotnick MJ, Nriagu JO. Validity of human nails as a biomarker of arsenic and selenium exposure:
A review. Environ Res. 2006; 102:125–139. [PubMed: 16442520]
49. Chiou HY, Hsueh YM, Hsieh LL, et al. Arsenic methylation capacity, body retention, and null
genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in
Taiwan. Mutat Res. 1997; 386:197–207. [PubMed: 9219558]
50. Mordukhovich I, Wright RO, Hu H, et al. Associations of Toenail Arsenic, Cadmium, Mercury,
Manganese and Lead with Blood Pressure in the Normative Aging Study. Environ Health
Perspect. 2012; 120:98–104. [PubMed: 21878420]
51. Mordukhovich I, Wright RO, Amarasiriwardena C, et al. Association between low-level
environmental arsenic exposure and QT interval duration in a general population study. Am J
Epidemiol. 2009; 170:739–746. [PubMed: 19700500]
52. Kamimura T, Miyamoto T, Harada M, Akashi K. Advances in therapies for acute promyelocytic
leukemia. Cancer Sci. 2011; 102:1929–1937. [PubMed: 21790894]
1. Wright RO, Schwartz J, Wright RJ, et al. Biomarkers of lead exposure and DNA methylation within
retrotransposons. Environ Health Perspect. 2010; 118:790–795. [PubMed: 20064768]
2. Madrigano J, Baccarelli A, Mittleman MA, et al. Prolonged exposure to particulate pollution, genes
associated with glutathione pathways, and DNA methylation in a cohort of older men. Environ
Health Perspect. 2011; 119:977–982. [PubMed: 21385671]
3. Baccarelli A, Wright RO, Bollati V, et al. Rapid DNA methylation changes after exposure to traffic
particles. Am J Respir Crit Care Med. 2009; 179:572–578. [PubMed: 19136372]
Lambrou et al. Page 14
Epidemiology. Author manuscript; available in PMC 2013 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Lambrou et al. Page 15
Epidemiology. Author manuscript; available in PMC 2013 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
FIGURE.
Estimated change in (A.) Alu and (B.) LINE-1 DNA methylation (% 5-mC), with 95%
confidence interval, per one interquartile increase (0.06μg/g) in toenail arsenic, by
nutritional factor status as measured in plasma. The median values of plasma concentrations
of folate, cobalamin (vitamin B12) and pyridoxine (vitamin B6) were used to divide
participants in low and high groups. The median values of plasma folate, vitamin B12 and
vitamin B6 were 14.1 ng/ml, 475.5 pg/ml, and 72.7 nmol/L, respectively. All models were
adjusted for age, laboratory batch, CpG locus number, percent lymphocytes, alcohol-
drinking status, and body mass index.
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TABLE 1
Characteristicsa of the study population at baseline visit (n=581) and by tertiles of toenail arsenic, 1999-2002
& 2006-2007
Tertiles of toenail arsenic (μg/gr)
Characteristic All (n=581) ≤0.061 (n=194) 0.062-0.096 (n=194) >0.096 (n=193)
Age (years) 72.0 (9.0) 73.0 (11.0) 69.0 (9.0) 71.0 (9.0)
Body mass index (kg/m2) 27.5 (4.7) 27.7 (5.3) 27.5 (5.0) 27.3 (3.9)
Lymphocytes (%) 25.0 (10) 24.0 (11) 25.0 (9) 26.0 (9)
Plasma folate (ng/mL)b 13.3 (10.9) 15.3 (12.6) 13.2 (10.4) 12.4 (9.4)
Plasma vitamin B12 (pg/mL)b 475.0 (262.5) 483.5 (278.0) 492.5 (255.5) 446.5 (231.0)
Plasma vitamin B6 (nmol/L)c 72.3 (80.6) 71.0 (76.1) 64.5 (65.5) 82.8 (85.2)
Pack years 10.0 (31.3) 9.8 (30.0) 11.1 (31.0) 10.0 (30.0)
Smoking status; No. (%)
    Never 175 (30) 66 (34) 50 (26) 59 (31)
    Former 386 (67) 122 (63) 138 (71) 126 (65)
    Current 20 (3) 6 (3) 6 (3) 8 (4)
Alcohol drinking; No. (%)
    >= 2 drinks/day 112 (19) 18 (9) 45 (23) 49 (25)
    < 2 drinks/ day 469 (81) 176 (91) 149 (77) 144 (75)
Season of visit; No. (%)
    Spring 160 (27) 67 (35) 49 (25) 44 (23)
    Summer 160 (28) 43 (22) 53 (27) 64 (33)
    Fall 172 (30) 43 (22) 59 (31) 70 (36)
    Winter 89 (15) 41 (21) 33 (17) 15 (8)
Alu methylation (% 5-mC)d 26.0 (1.3) 26.1 (1.4) 26.0 (1.2) 25.8 (1.2)
    CpG position 1 35.0 (2.1) 35.0 (2.2) 35.1 (1.9) 34.8 (2.2)
    CpG position 2 25.8 (1.6) 26.0 (1.6) 25.7 (1.7) 25.7 (1.5)
    CpG position 3 16.8 (1.4) 17.0 (1.5) 16.8 (1.1) 16.7 (1.5)
LINE-1 methylation (% 5-mC)d 77.3 (2.8) 77.1 (2.3) 77.2 (2.8) 77.6 (3.7)
    CpG position 1 82.3 (3.0) 82.2 (2.4) 82.0 (3.0) 82.8 (3.1)
    CpG position 2 75.1 (3.4) 74.8 (2.8) 75.2 (3.6) 75.4 (3.9)
    CpG position 3 74.8 (3.5) 74.3 (3.0) 74.8 (3.6) 75.0 (4.5)
a
Median (IQR), unless otherwise indicated
bAvailable for 544 subjects (182, 180 and 182 subjects in the 1st, 2nd, and 3rd tertile of arsenic distribution, respectively)
cAvailable for 539 subjects (181, 181 and 177 subjects in the 1st, 2nd, and 3rd tertile of arsenic distribution, respectively)
d
The average of the three CpG loci DNA methylation
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TABLE 2
Estimated change in DNA methylation in Alu and LINE-1 repetitive elements associated with an interquartile
range (0.06 μg/g) increase in toenail arsenic concentrations among Normative Aging Study participants,
1999-2002 & 2006-2007 (n=2205 observations).
Outcome Change in methylation for an IQR change in toenail Arsenic (μg/g) (95% CI)
Alu DNA methylation (% 5-mC)
    Model 1a 0.03 (-0.01 to 0.07)
    Model 2b 0.03 (-0.01 to 0.07)
    Model 3c 0.03 (-0.01 to 0.07)
LINE-1 DNA methylation (% 5-mC)
    Model 1a -0.05 (-0.11 to 0.02)
    Model 2b -0.05 (-0.11 to 0.02)
    Model 3c -0.05 (-0.11 to 0.02)
a
Model 1 is a multivariable mixed effects models adjusted for age, laboratory batch, CpG locus number, percent lymphocytes, drinking status, and
body mass index.
b
Model 2 is model 1 additionally adjusted for smoking status and pack-years.
c
Model 3 is model 2 additionally adjusted for season and day of the week.
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TABLE 3
Estimated changes in Alu and LINE-1 DNA methylation associated with changes in the covariates among
Normative Aging Study participants with complete data on plasma folate and vitamins B12 and B6, 1999-2002
& 2006-2007 (n=2064 observations).
Covariate Alu (% 5-mC) β (95% CI)a LINE-1 (% 5-mC) β (95% CI)a
Model 1
Toenail Arsenic (μg/g)
-0.08 (-0.17 to 0.01)c -0.02 (-0.15 to 0.11)c
Low folateb -0.30 (-0.53 to -0.06) 0.24 (-0.12 to 0.61)
Toenail Arsenic 0.16 (0.06 to 0.26) -0.03 (-0.19 to 0.12)
*Low folate
Model 2
Toenail Arsenic (μg/g) 0.01 (-0.06 to 0.09)c -0.26 (-2.21 to 1.70)c
Low vitamin B12
b -0.22 (-0.44 to 0.01) 0.22 (-0.13 to 0.56)
Toenail Arsenic 0.05 (-0.04 to 0.13) -0.69 (-2.96 to 1.58)
*Low vitamin B12
Model 3
Toenail Arsenic (μg/g) 0.01 (-0.07 to 0.09)c 0.01 (-0.12 to 0.13)c
Low vitamin B6
b 0.08 (-0.15 to 0.31) 0.34 (-0.02 to 0.70)
Toenail Arsenic 0.04 (-0.06 to 0.13) -0.07 (-0.22 to 0.08)
*Low vitamin B6
β indicates regression coefficient.
a
From multivariable mixed effects models additionally adjusted for age, laboratory batch, CpG locus number, percent lymphocytes, alcohol
drinking status, and body mass index.
b
The median values of plasma concentrations of folate, cobalamin (vitamin B12) and pyridoxine (vitamin B6) were used to divide participants in
low and high groups. The median values of plasma folate, vitamin B12 and vitamin B6 were 14.1ng/ml, 475.5pg/ml, and 72.7nmol/L, respectively.
c
Estimated change in Alu or LINE-1 DNA methylation for an interquartile range (0.06μg/g) increase in toenail arsenic concentration.
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